21¼¼±â ÀáÀÚ´Â ½£¼ÓÀÇ °øÁÖ - °æµµÀÎÁöÀå¾Ö¿Í Ä¡¸Å Ä¡·á±â: ÀáÀÚ´Â ³ª¶ó ½Ã¸®Áî 1INFOMEDPRESS, 2021. 7. 23. - 123ÆäÀÌÁö ÀÌÁ¾ÈÆÀº °æµµÀÎÁöÀå¾Ö¿¡ ´ëÇÑ Ä¡·á¹ýÀÌ ¾ø´Ù´Â °ÍÀ» ¾Ë°Ô µÈ 2008³âºÎÅÍ ±âÃÊ ÀÇÇп¡ ´ëÇÑ ¿¬±¸¸¦ ´Ù½Ã ¼öÇàÇÏ¿´´Ù. Á¤ºÎ Áö¿ø ¾øÀÌ ¼ø¼ö °³ÀÎ ¿¬±¸·Î Ä¡·á¹ý°ú ¿¹¹æ¹ýÀ» ¹ß°ßÇÏ°í ³í¹®ÈÇÏ¿© ¹ßÇ¥Çß´Ù. (Lee JH, Choi SH, Lee CJ, Oh SS. Recovery of Dementia Syndrome following Treatment of Brain Inflammation. Dement Geriatr Cogn Dis Extra. 2020;10(1):1-12.) 2010³âºÎÅÍ ¼¿ï´ëÇб³ Àǰú´ëÇп¡ ¿¬±¸ ÄÚȣƮ¸¦ ±¸¼ºÇÏ¿© 2021³â 1¿ù 3ÀϱîÁö Ä¡·á °æ°ú¸¦ °üÂûÇÏ°í ¼Ò·Ïµµ ÄÚȣƮ ¿¬±¸¸¦ ÅëÇÏ¿© Áý´Ü ¿¬±¸ °á°ú¸¦ ¶ÇÇÑ ³í¹®È ÇÏ°í ¹ßÇ¥ÇÏ¿´´Ù. (Lee JH, Kanwar B, Lee CJ, Sergi C, Coleman M. Dapsone is an anticatalysis for Alzheimer¡¯s disease exacerbation. iScience. 2022;under review.) ƯÈ÷ Ä¡¸Å¾à¿¡ ÀÇÇÏ¿© Çѱ¹Àο¡°Ô »ç¸ÁÀÚ¼ö°¡ Áõ°¡ÇÑ´Ù´Â ³í¹®Àº Àü¼¼°èÀûÀ¸·Î Å« Ãæ°ÝÀ» ÁÖ¾ú´Ù. Ȧ·ÎÄÚ½ºÆ®¿¡ ¹ö±Ý°¡´Â ¾à¹° ºÎÀÛ¿ëÀ» ³íÁõÇÏ¿´´Ù. (Lee JH. The listed, delisted, and sustainability of therapeutic medicines for dementia patients: the study is specific to South Korea. Naunyn-Schmiedeberg's Archives of Pharmacology. 2022.) |

